Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Syntara clinical trials
Also known as Pharmaxis.
The registry lists 31 studies whose lead sponsor is Syntara. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 4, 2026.
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Syntara.
- Syntara31 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 31 of 31.
- Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary, Post-polycythemia Vera or Post-essential Thrombocythemia MyelofibrosisCompletedNCT04676529Phase 1/2
- Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour DisorderActive, not recruitingNCT05904717Phase 2
- A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis SubjectsCompletedNCT02134353Phase 3
- Long Term Administration of Inhaled Mannitol in Cystic FibrosisCompletedNCT00630812Phase 3
- A Two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult MalesCompletedNCT04183517Phase 1
- A Pilot Safety Study of Inhaled Dry Powder Mannitol in Acute Exacerbations of COPDWithdrawnNCT00446667Phase 1/2
- Inhaled Mannitol as a Mucoactive Therapy for BronchiectasisCompletedNCT00669331Phase 3
- Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPDCompletedNCT00117182Phase 2
- Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 YearsCompletedNCT01883531Phase 2
- Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With AsthmaCompletedNCT00550797Phase 2
- Efficacy and Safety of Four Escalating Dose Regimens of TPI ASM8 in Patients With Allergic AsthmaCompletedNCT00822861Phase 2
- Efficacy of TPI ASM8 During a 14-Day Allergen ChallengeCompletedNCT01158898Phase 2
- Multiple Dose ASM8 in Mild AsthmaticsCompletedNCT00264966Phase 1/2
- Safety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic PatientsTerminatedNCT00402948Phase 2
- Safety, Tolerability and PD Activity of Inhaled TPI 1020 Versus Inhaled Budesonide in COPD PatientsCompletedNCT00483743Phase 2
- A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe AsthmaWithdrawnNCT01380236Phase 2
- Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible AsthmaCompletedNCT00327808Phase 2
- Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Inhaled TPI 1100 in Healthy VolunteersWithdrawnNCT00914433Phase 1
- Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy StudyCompletedNCT00446680Phase 3
- High Dose Inhaled Mannitol StudyCompletedNCT01076491Phase 1/2
- A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic FibrosisCompletedNCT00455130Phase 2
- Comparison of Inhaled Mannitol and rhDNase in Children With Cystic FibrosisCompletedNCT00117208Phase 2
- Pharmacokinetics of Inhaled Mannitol in Cystic Fibrosis PatientsCompletedNCT00792714Phase 1
- Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected AsthmaticsCompletedNCT00252291Phase 3
- A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler DeviceCompletedNCT00730977Phase 1/2
- Cystic Fibrosis (CF) Flow Rates StudyCompletedNCT00779077
- Safety and Efficacy of Bronchitol in BronchiectasisCompletedNCT00277537Phase 3
- Mannitol Dose Response Study in Cystic FibrosisCompletedNCT00251056Phase 2
- Inspiratory Flow and Volumes in BronchiectaticsCompletedNCT00656565
- Inspiratory Flow Using the OsmohalerCompletedNCT00531414
- A Pharmacokinetic and Bioavailability Study of Mannitol for Inhalation Using Normal SubjectsCompletedNCT00446771Phase 1